PYC pyc therapeutics limited

0.40%

$1.27

Can anyone explain this. I have an order in the market. There is...

First 10 Last

Share
Profile

Follow
travelbug2

6,834 Posts.

383

04/10/16

13:21

Post #: 19607798
Share

Originally posted by waynesworld ↑

Of some interest was the fact that there was no update on the leadership roles. Its self-apparent, however, that someone is making executive decisions.

The leadership vacuum doesn't appear to be unsettling the progression of the science, negotiations with Pharma or even the share price (despite consistent selling). Presumably, as pointed out by Lionhearted, "Richard's chair was not cold for longer than a couple of weeks".

If anything as far as the science is concerned, there appears to be a sharp focus in building towards pre-clinical or as ds makes the point "seems like more progress or information in 3-4 months than the 6 months prior".

Left field may have a lot to offer. Watch out for a fast ball from the FPP delivery platform. Given that peptide delivery is not new but problematic because of adverse side effects, there appears to be positive signs in relation to the safety of FPP's.

Expand

Can anyone explain this. I have an order in the market. There is someone in front of me. My order got partfilled at .015c today. No trades on commsec at that price. So clearly it is on chix but surely the other order should have got done before mine???

PYC Price at posting: 1.6¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

First 10 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.27		Change 0.005(0.40%)		Mkt cap ! $740.7M

Open	High	Low	Value	Volume
$1.27	$1.29	$1.27	$406.0K	319.3K

Buyers (Bids)

No.	Vol.	Price($)
1	13987	$1.27

Sellers (Offers)

Price($)	Vol.	No.
$1.29	1380	1

View Market Depth

No.	Vol.	Price($)
1	13987	1.265
2	16380	1.260
3	14380	1.255
3	103380	1.250
1	4000	1.225

Price($)	Vol.	No.
1.285	1380	1
1.290	27010	3
1.295	25880	2
1.300	59168	4
1.325	9001	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

PYC (ASX) Chart

Can anyone explain this. I have an order in the market. There is...

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Can anyone explain this. I have an order in the market. There is...

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Boss extends June win streak with boosted Alta Mesa extraction rates

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News